Hair Growth & Scalp Health (Hair Follicle Regeneration) Dosage: 23 mg per day (SC injection) or topical scalp application Cycle: 812 weeks, followed by a 4-week break Administration: Injectable: Subcutaneous micro-injections into the scalp (once weekly) Topical: Applied daily in a hair serum or spray Stacking: With RU58841 or Finasteride for DHT blocking With Minoxidil (Rogaine) for enhanced follicle stimulation With Red light therapy (LLLT) for scalp blood flow improvement Expected Benefits: Increased hair follicle activation and regrowth Reduced hair thinning and shedding Improved scalp health and reduced inflammation 4
Canadian Regulatory Context GHK-Cu occupies an interesting regulatory position in Canada
All tissue procured has been screened by using Chagas enzyme immunoassay (EIA) test antibodies to the human immunodeficiency virus, type 1 and type 2 (anti-HIV-1 and anti-HIV-2) Plus O, Nucleic Acid Test (NAT) for HIV-1, hepatitis B surface antigen (HbsAg), hepatitis B, core total Ab, hepatitis C virus Ab (anti-HCV), cytomegalovirus (CMV) total Ab, HTLV I/II Ab, West Nile virus (WNV), ZIKA NAT, Nucleic Acid Test (NAT) for the hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HBV/HCV), syphilis, and Lyme disease
Tendon and ligament injuries (stalled recovery): Patients with subacute tendinopathy that has plateaued in PT typically notice a meaningful change in pain level and range of motion within 3 to 4 weeks
Key Indications: Circadian rhythm disruption and sleep-wake imbalance Age-related neuroendocrine changes Longevity and healthy aging support Vascular and microcirculatory support Recommended Dosage 12 sprays sublingually, once daily or as directed by your healthcare professional
